BIO BIO バイオ・ラッド・ラボラトリ―ズ

 BIOのチャート


 BIOの企業情報

symbol BIO
会社名 Bio-Rad Laboratories Inc (BIO バイオ・ラッド・ラボラトリ―ズ)
分野(sector)   
産業(industry)   
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 バイオ・ラッド・ラボラトリーズ(Bio-Rad Laboratories Inc.)は複合化学材料及び生物材料の分離またはその成分の識別・分析・浄化に応用される各種製品及びシステムの製造会社である。同社製品は主にライフサイエンス研究、保健及び分析化学等の分野に提供されている。同社はライフサイエンス事業及び臨床診断事業の2つの事業区分により構成される。平成23年12月期決算期において、ライフサイエンス事業及び臨床診断事業の純売上高はそれぞれ同社総純売上高の33%と66%を占めた。平成23年12月期決算期において、ライフサイエンス事業及び臨床診断事業の純売上高はそれぞれ同社の総合純売上高の33%と66%を占めた。平成23年度において、同社の連結売上高の約30%は米国販売事業から、70%は世界中その他市場事業から生じた。平成23年12月31日現在、同社は子会社を通じて、米国以外の35以上の国での直接流通チャネルを所有している。  バイオ・ラッド・ラボラトリ―ズは、米国の医薬品会社。事業は2部門で構成される。ライフサイエンス部門は、実用的なゲノミクス、プロテオミクス、食品安全性の研究に使用される多様な実験用機器、装置、および消耗品の開発、製造、および販売を行う。診断薬部門は、医学的スクリ―ニングおよび診断向けの幅広い製品の開発、製造、販売、およびサポ―トを行う。  Bio-Rad Laboratories, Inc. is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, its products advance the discovery process and improve healthcare. Bio-Rad's customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology and pharmaceutical companies, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 7,800 employees worldwide. Bio-Rad had revenues exceeding $2.5 billion in 2020.
本社所在地 510 724-7000
代表者氏名 Norman D. Schwartz
代表者役職名 Chairman of the Board President Chief Executive Officer
電話番号 +1 510-724-7000
設立年月日 1952年
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 8260人
url www.bio-rad.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 345.37900
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 9145.17200
売上高 売上高(百万ドル) 2290.10900
企業価値(EV) 企業価値(EV)(百万ドル) 8734.24600
当期純利益 当期純利益(百万ドル) 311.99600
決算概要 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Bio-Rad Laboratories Inc. revenues increased 6% to $2.29B. Net income before extraordinary items increased from $52.2M to $312M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Acquisition Cost decrease from $10M (expense) to $0K Restructuring Charges_Provisions decrease of 90% to $855K (expense).

 BIOのテクニカル分析


 BIOのニュース

   Electrophoresis Equipment and Supplies Market Report 2021-2028 | Size, Share, Growth, Trends, Analysis, Competitive Landscape, Revenue, Forecast  2021/08/06 10:27:00 Intrado Digital Media
Key Companies Covered in the Electrophoresis Equipment and Supplies Market Research Report are Bio-Rad Laboratories Inc., Agilent Technologies, PerkinElmer Inc., Merck KGaA, Thermo Fisher Scientific Inc., Beckman Coulter Inc., Hoefer Inc., Lonza Group Ltd., SERVA Electrophoresis GmbH, C.B.S Scientific Company Inc., QIAGEN, Helena Laboratories Corporation Key Companies Covered in the Electrophoresis Equipment and Supplies Market Research Report are Bio-Rad Laboratories Inc., Agilent Technologies, PerkinElmer Inc., Merck KGaA, Thermo Fisher Scientific Inc., Beckman Coulter Inc., Hoefer Inc., Lonza Group Ltd., SERVA Electrophoresis GmbH, C.B.S Scientific Company Inc., QIAGEN, Helena Laboratories Corporation
   Point-of-Care Testing Market Demonstrates A Spectacular Growth By 2026 | Roche Diagnostics, Beckman Coulter, Bio-Rad Laboratories  2021/08/05 15:15:00 iCrowdNewswire
The Latest Released Point-of-Care Testing market study has evaluated the future growth potential of Global Point-of-Care Testing market and provides information and useful stats on market structure and size. The report is []
   Cell Separation Technologies Market 2021 Precise Outlook- Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Corning Incorporated, Danaher corporation  2021/08/05 11:52:52 OpenPR
The Global Cell Separation Technologies Market Research Report 2021-2027 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The
   Impact of COVID-19 on Gas Chromatography (GC) Market Forecast 2028 | Business Opportunities and Analysis by Key Players: General Electric Company, Shimadzu, Danaher, Dani Instruments, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, R  2021/08/05 05:18:23 OpenPR
Gas chromatography (GC) is an analytic technique use in research and industrial laboratories for identification, quantification of compounds in a mixture and quality control. The technique has wide range of applications in biotechnology, forensic science and environment science. It can
   South and Central America Custom Antibody Market Growth Set to Surge Significantly during 2021 2028 |Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Merck KGAA, Abcam, Genscript, Agilent Technologies, Inc., etc.  2021/08/03 09:30:40 OpenPR
The Custom antibody market in South and Central America is expected to grow from US$ 23.9 million in 2021 to US$ 45.9 million by 2028; it is estimated to grow at a CAGR of 9.8% from 2021 to 2028. Customized antibodies
   Insights on the NGS Sample Preparation Global Market to 2027 key players are Agilent Technologies, Bio-Rad Laboratories, Inc., etc  2021/07/02 09:04:46 Jumbo News
NGS Sample Preparation Market Size USD 3.11 Billion in 2019, NGS Sample Preparation Market Growth CAGR of 9.3%, NGS Sample Preparation Market Trends High demand in the consumer genomics sector. The Global NGS Sample Preparation Market is projected to reach USD 6.63 billion in 2027. Numerous advantages of high-performance sequencing compared to other genetic technologies, such []
   Seegene inks partnership with Bio-Rad to sell its diagnostic tests in the US  2021/07/01 08:41:11 KoreaHerald
South Korean diagnostics company Seegene said Thursday that the company has partnered with Bio-Rad Laboratories for the
   Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products  2021/06/30 21:00:00 Business Wire
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced a partners
   DGAP-News: Biotest AG: Biotest AG opens fifth plasma collection centre in Czech Republic  2021/06/30 05:00:09 Wallstreet:Online
DGAP-News: Biotest AG / Key word(s): Miscellaneous Biotest AG: Biotest AG opens fifth plasma collection centre in Czech Republic 30.06.2021 / 07:00 The issuer is solely responsible for the content of this announcement. PRESS RELEASE Biotest AG opens fifth plasma collection centre in Czech Republic
   Global malaria diagnostics market is expected to reach $1,085,106 thousand by 2026 | Access Bio. Inc., Siemens AG., Bio-Rad Laboratories, Inc., Premier Medical Corporation Pvt Ltd., Atlas Medical  2021/06/28 04:02:18 OpenPR
According to the report, the global malaria diagnostics industry was estimated at $728,870 thousand in 2018, and is expected to hit $1,085,106 thousand by 2026, registering a CAGR of 5.1% from 2019 to 2026. Drivers, restraints, and opportunities: Rise in incidence of
   US High-Performance Liquid Chromatography (HPLC) Market Report 2020-2026: Key Players Include Agilent Technologies, PerkinElmer, Thermo Fisher Scientific, Waters, Bio-Rad Laboratories & Gilson  2021/06/04 21:45:00 Business Insider Markets
DUBLIN, June 4, 2021 /PRNewswire/ -- The "US High-Performance Liquid Chromatography (HPLC) Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The US high-performance liquid…
   Cell Analysis Global Market - Forecast to 2027: Focus on Consumables, Instruments & Software and Services  2021/06/01 23:00:00 Benzinga
DUBLIN , June 1, 2021 /PRNewswire/ -- The "Cell Analysis Global Market - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The cell analysis global market is expected to reach $33,542.0 million by 2027 growing at a mid-single-digit CAGR from 2020 to 2027 Market growth is due to rising incidence of infectious and non-infectious diseases and demand for early detection, diagnosis & treatment, increasing government and private funding, increasing advancements in cell imaging technologies to reduce the cost & time during the drug discovery process, growing focusing on personalized medicine, the introduction of advanced technologies in single-cell analysis and emerging Asia-Pacific market. However, stringent government regulations, lack of skilled personnel to use advanced cell analysis Instruments, and the high cost of some of the instruments are expected to hamper the market growth. The Asia-Pacific is the fastest-growing region in the cell analysis global market at a mid single-digit CAGR from 2020 to 2027 which is attributed to the increased scope for research activities in academic & research institutes, increasing outsourcing, increased incidence of chronic diseases (cancer) and infectious disease, increasing awareness about early screening (cancer) and prenatal test and their adoption in clinical care, increasing government and private investment for - cell-based research and also for the development & expansion single-cell analysis technologies and increasing number startup companies engaged in the development innovative solutions.
   Insights on the Rapid Microbiology Testing Global Market to 2027 - Featuring Abbott, Bio-Rad Laboratories and Merck Among Others  2021/05/28 19:42:00 Benzinga
DUBLIN , May 28, 2021 /PRNewswire/ -- The "Rapid Microbiology Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the global market for Rapid Microbiology Testing estimated at US$3.9 Billion in the year 2020, is projected to reach a revised size of US$6.2 Billion by 2027, growing at a CAGR of 6.8% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents & Kits segment is readjusted to a revised 7.4% CAGR for the next 7-year period. The U.S. Market is Estimated at $1.1 Billion , While China is Forecast to Grow at 10.4% CAGR The Rapid Microbiology Testing market in the U.S. is estimated at US$1.1 Billion in the year 2020. China , the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2027 trailing …

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 BIO バイオ・ラッド・ラボラトリ―ズ BIO )

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)